School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
School of Biomedical Science, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Toxicol Appl Pharmacol. 2019 Aug 15;377:114613. doi: 10.1016/j.taap.2019.114613. Epub 2019 Jun 14.
Realgar and cinnabar are commonly used mineral medicine containing arsenic and mercury in Traditional Chinese Medicine (TCM). Angong Niuhuang Wan (AGNHW) is a representative realgar- and cinnabar-containing TCM formula for treating acute ischemic stroke, but its toxicology and neuropharmacological effects are not well addressed. In this study, we compared the neuropharmacological effects of AGNHW and modified AGNHW in an experimental ischemic stroke rat model. Male SD rats were subjected to 2 h of middle cerebral artery occlusion (MCAO) plus 22 h of reperfusion. Although oral administration of AGNHW for 7 days in the rats increased arsenic level in the blood and liver tissue, there were no significant changes in the arsenic level in kidney, mercury level in the blood, liver and kidney as well as hepatic and renal functions in MCAO rats. AGNHW revealed neuroprotective properties by reducing infarction volume, preserving blood-brain barrier integrity and improving neurological functions against cerebral ischemia-reperfusion injury. Interestingly, removing realgar and/or cinnabar from AGNHW abolished the neuroprotective effects. Meanwhile, AGNHW could scavenge peroxynitrite, down-regulate the expression of p47, 3-NT and MMP-9 and up-regulate the expression of ZO-1 and claudin-5 in the ischemic brains, which were abolished by removing realgar and/or cinnabar from AGNHW. Notably, realgar or cinnabar had no neuroprotection when used alone. Taken together, oral administration of AGNHW for one week should be safe for treating ischemic stroke with neuroprotective effects. Realgar and cinnabar are necessary elements with synergetic actions with other herbal materials for the neuroprotective effects of AGNHW against cerebral ischemia-reperfusion injury.
雄黄和朱砂是中药中常用的含砷和汞的矿物药。安宫牛黄丸(AGNHW)是一种治疗急性缺血性脑卒中的典型含雄黄和朱砂的中药方剂,但它的毒理学和神经药理学作用尚未得到充分阐明。在本研究中,我们比较了 AGNHW 和改良 AGNHW 在实验性缺血性脑卒中大鼠模型中的神经药理学作用。雄性 SD 大鼠接受 2 小时大脑中动脉闭塞(MCAO)加 22 小时再灌注。虽然 AGNHW 连续给药 7 天可增加大鼠血液和肝组织中的砷含量,但 MCAO 大鼠血液中的砷、肝和肾组织中的汞以及肝肾功能均无明显变化。AGNHW 通过减少梗死体积、保护血脑屏障完整性和改善神经功能来发挥神经保护作用,减轻脑缺血再灌注损伤。有趣的是,从 AGNHW 中去除雄黄和/或朱砂会消除其神经保护作用。同时,AGNHW 可以清除过氧亚硝酸盐,下调 p47、3-NT 和 MMP-9 的表达,上调缺血脑组织中 ZO-1 和 Claudin-5 的表达,而从 AGNHW 中去除雄黄和/或朱砂则会消除这些作用。值得注意的是,单独使用雄黄或朱砂没有神经保护作用。总之,连续口服 AGNHW 一周治疗缺血性脑卒中是安全的,具有神经保护作用。雄黄和朱砂是 AGNHW 对脑缺血再灌注损伤具有神经保护作用的必需元素,与其他草药材料具有协同作用。